Table 1.
Background characteristics of the subjects enrolled in ASSAF-K.
| Parameter | Total (N=3847) |
|---|---|
| Age | 72.9±10.1 |
| Male:Female | 2512:1335 |
| Body mass index, kg/m² | 23.4±3.6 |
| SBP/DBP (mmHg) | 126.5±16.3/ |
| 73.1±11.5 | |
| PR (bpm) | 74.5±18.8 |
| Cr (mg/dL) | 1.08±1.17 |
| CCr | 66.6±28.6 |
| eGFR | 59.6±19.5 |
| Clinical Score | |
| CHADS2 Score | 1.81±1.27 |
| CHADS2 Vasc Score | 3.02±1.58 |
| HAS BLED Score | 2.23±1.06 |
| Concomitant diseases | |
| CHF | 22.90% |
| Hypertension | 60.10% |
| Diabetes Mellitus | 20.20% |
| Cerebral Infarction | 13.70% |
| Cerebral Hemorrhage | 0.90% |
| TIA | 2.10% |
| OMI | 5.90% |
| Angina pectoris | 9.00% |
| PAD | 2.30% |
| HCM | 1.70% |
| DCM | 2.10% |
| Liver Dysfunction | 1.40% |
| Hemorrhagic Disease | 1.10% |
| Hemodyalisis | 1.50% |
| Neoplasm | 4.30% |
| Thyroid Dysfunction | 3.00% |
| Interventional procedures | |
| PCI | 10.70% |
| Catheter Ablation | 5.80% |
| Maze Operation | 0.50% |
| DC | 1.00% |
| Pharmacological Defibrillation | 0.20% |
| Concomitant structural heart diseases | |
| Mitral Stenosis | 1.90% |
| Mitral Regurgitation | 14.10% |
| Mechanical Valve Replacement | 1.90% |
| Biological Valve Replacement | 0.50% |
| Other Valvular Disease | 5.50% |
| Medications | |
| Digitalis | 15.90% |
| β-blockade | 32.90% |
| Calcium Channel Blockade | 11.50% |
| Other Anti-arrhythmic Drugs | 16.20% |
| Anti-platelet medications | |
| ASA | 18.50% |
| Ticlopidine | 1.10% |
| Clopidogrel | 3.70% |
| Cilostazol | 1.20% |
| Anti-coagulant medications | |
| Warfarin | 44.20% |
| All NOAC | 33.50% |
| Dabigatran | 15.00% |
| Ribaroxaban | 15.00% |
| Apixaban | 3.50% |
| Edoxaban | 0.02% |
Abbreviations: ASA, acetylsalicylic acid; Cr, creatinine; CCr, creatinine clearance; CHF, chronic heart failure; DC, direct current defibrillation; DCM, dilated cardiomyopathy; eGFR, estimated glomerular filtration rate; HCM, hypertrophic cardiomyopathy; NOAC, new oral anticoagulant; OMI, old myocardial infarction; PAD, peripheral aretery disease; PCI, percutaneous coronary intervention; PR, pulse rate; SBP/DBP, systolic blood pressure/diastolic blood pressure; TIA, transient ischemic attack